All News
Filter News
Found 806,088 articles
-
Aspen Neuroscience Announces Board of Directors and Scientific Advisory Board
1/9/2020
World-renowned leaders will guide Aspen's efforts to develop the first personalized cell therapy for Parkinson disease
-
Another 160 Pharmacies Adopt Digital Pharmacist's 2-Way Messaging Product
1/9/2020
Digital Pharmacist, a rapidly growing software company that powers digital communication and adherence solutions for more than 7,500 pharmacies, announced that another 160 pharmacies have adopted its new 2-way messaging platform.
-
Surgeons at Duke University Hospital Use Advanced Preservation and Transportation System to Safeguard Donor Heart During Journey Between Donor and Recipient
1/9/2020
Duke University Hospital has transported its first donor heart using the only commercially available FDA cleared and CE marked system for cold donor heart storage and transport.
-
Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
1/9/2020
Galafold Revenue of $181 Million for Full-Year 2019 and $54 Million in Q4 Reflects Continued Strong Adoption & Patient Adherence in All Key Global Regions
-
Rush University System for Health Selects R1 RCM for End-to-End Revenue Cycle Management to Drive Performance Excellence and Accelerate Innovation
1/9/2020
R1 RCM Inc. announced that Rush University System for Health has entered into a strategic partnership to achieve revenue cycle performance excellence and accelerate innovation in healthcare.
-
Eagle Pharmaceuticals Resubmits NDA for RYANODEX for Exertional Heat Stroke
1/9/2020
Eagle Pharmaceuticals, Inc. announced that the Company has resubmitted its New Drug Application for RYANODEX® for the treatment of exertional heat stroke, in addition to body cooling, to the U.S. Food and Drug Administration.
-
Organ donation again sets record in 2019
1/9/2020
Nearly 11,900 people provided the lifesaving gift of organ donation upon their death last year, making 2019 the ninth consecutive record-breaking year for deceased donation in the United States.
-
Osceola Capital Announces Acquisition of Healthcents
1/9/2020
Osceola Capital, a lower middle-market private equity firm focused on services businesses, announced the acquisition of Healthcents, Inc., a leading provider of medical reimbursement and related services.
-
Co-Diagnostics, Inc. Invited to Ring Nasdaq Opening Bell Following Several Milestone Events
1/9/2020
Co-Diagnostics, Inc. announced that it has been recognized as a company that represents the Nasdaq Biotech Index in leading the nation in solving America’s Healthcare challenges following a year of several Company milestones, and invited to ring the Nasdaq Stock Market opening bell on January 13 in San Francisco, California.
-
Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer
1/9/2020
Zai Lab Limited and Novocure announced that the first patient has been enrolled in a phase 2 pilot clinical trial evaluating the safety and efficacy of Tumor Treating Fields in combination with chemotherapy as a first-line treatment in patients with gastric adenocarcinoma.
-
BD Announces Live Webcast Of First Fiscal Quarter 2020 Earnings Conference Call
1/9/2020
BD announced that it will conduct a live webcast of its first fiscal quarter 2020 earnings conference call on Thursday, February 6, 2020, at 8:00 a.m.
-
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
1/9/2020
WuXi Biologics announced the signing of a strategic collaboration agreement enabling Almirall to leverage the proprietary WuXiBody™ platform to develop bispecific antibodies for dermatological diseases.
-
Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference
1/9/2020
Sutro Biopharma, Inc. announced that the company will present at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, Jan. 16, 2020, at 9:00 AM PST at the Westin St. Francis in San Francisco.
-
Ultragenyx Announces Positive Topline Cohort 3 Results and Improved Longer-Term Cohort 2 Results from Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
1/9/2020
More uniform response in Cohort 3 with two confirmed responders and one potential responder
-
Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference
1/9/2020
Novavax, Inc. announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference.
-
American Brain Tumor Association and Uncle Kory Foundation Announce Partnership to Accelerate Brain Tumor Research
1/9/2020
American Brain Tumor Association announced a new partnership with the Uncle Kory Foundation to accelerate brain tumor research.
-
Fusion Genomics Receives $1 Million Award to Evaluate Novel Genomic Diagnostics Platform in Collaboration with Sunnybrook Research Institute
1/9/2020
Project funded through CQDM Quantum Leap program with support from Merck will explore potential of Fusion’s ONETest to improve diagnosis of respiratory tract infections
-
Enanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare Conference
1/9/2020
Presentation and Q&A breakout to be webcast on January 13, 2020 beginning at 2:30 p.m. Pacific Time.
-
Jorjin and Gigabyte Join Forces to Showcase a Smart Pharmacy Solution and a New Family of AR Smart Glasses at CES 2020
1/9/2020
Jorjin Technologies, who started working on smart glasses when AR was still in its infancy, will be partnering with Gigabyte at this year's CES on a joint AR-based end-to-end solution for Smart Pharmacies.
-
Emergex Raises More Than US$11 Million in a Series A Round to Progress Its Pipeline of Set-Point Vaccines for Infectious Diseases
1/9/2020
Emergex Vaccines Holding Limited, a biotechnology company developing set-point vaccines to prevent serious infectious diseases, announced that it has secured over US$11 million in a Series A round.